Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of GBP 105.42 billion. The enterprise value is 141.61 billion.

Market Cap	105.42B
Enterprise Value	141.61B

Important Dates

The last earnings date was Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	Jul 25, 2025

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.92%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.68B

Valuation Ratios

The trailing PE ratio is 13.45 and the forward PE ratio is 9.04.

PE Ratio	13.45
Forward PE	9.04
PS Ratio	2.26
PB Ratio	1.62
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.44, with an EV/FCF ratio of 15.61.

EV / Earnings	18.06
EV / Sales	3.01
EV / EBITDA	7.44
EV / EBIT	10.74
EV / FCF	15.61

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.70.

Current Ratio	1.16
Quick Ratio	0.78
Debt / Equity	0.70
Debt / EBITDA	2.42
Debt / FCF	4.99
Interest Coverage	6.26

Financial Efficiency

Return on equity (ROE) is 12.17% and return on invested capital (ROIC) is 7.18%.

Return on Equity (ROE)	12.17%
Return on Assets (ROA)	5.25%
Return on Invested Capital (ROIC)	7.18%
Return on Capital Employed (ROCE)	10.53%
Revenue Per Employee	574,647
Profits Per Employee	96,793
Employee Count	81,000
Asset Turnover	0.30
Inventory Turnover	1.45

Taxes

Income Tax	-171.36M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.08% in the last 52 weeks. The beta is 0.44, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-14.08%
50-Day Moving Average	24.49
200-Day Moving Average	25.14
Relative Strength Index (RSI)	57.10
Average Volume (20 Days)	60,171

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.58

Income Statement

In the last 12 months, Pfizer had revenue of GBP 46.55 billion and earned 7.84 billion in profits. Earnings per share was 1.38.

Revenue	46.55B
Gross Profit	34.36B
Operating Income	12.93B
Pretax Income	7.68B
Net Income	7.84B
EBITDA	17.87B
EBIT	12.93B
Earnings Per Share (EPS)	1.38

Full Income Statement

Balance Sheet

The company has 9.66 billion in cash and 45.24 billion in debt, giving a net cash position of -35.58 billion.

Cash & Cash Equivalents	9.66B
Total Debt	45.24B
Net Cash	-35.58B
Net Cash Per Share	n/a
Equity (Book Value)	64.91B
Book Value Per Share	11.38
Working Capital	4.36B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.07 billion and capital expenditures -2.01 billion, giving a free cash flow of 9.07 billion.

Operating Cash Flow	11.07B
Capital Expenditures	-2.01B
Free Cash Flow	9.07B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 73.82%, with operating and profit margins of 27.78% and 16.84%.

Gross Margin	73.82%
Operating Margin	27.78%
Pretax Margin	16.50%
Profit Margin	16.84%
EBITDA Margin	38.39%
EBIT Margin	27.78%
FCF Margin	19.49%

Dividends & Yields

This stock pays an annual dividend of 1.31, which amounts to a dividend yield of 5.35%.

Dividend Per Share	1.31
Dividend Yield	5.35%
Dividend Growth (YoY)	-1.08%
Years of Dividend Growth	1
Payout Ratio	89.68%
Buyback Yield	-0.92%
Shareholder Yield	4.43%
Earnings Yield	7.44%
FCF Yield	8.60%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 1, 1999. It was a forward split with a ratio of 3.

Last Split Date	Jul 1, 1999
Split Type	Forward
Split Ratio	3

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	8